Friday, July 10, 2026

biotech · Huntington’s Disease · Amyotrophic Lateral Sclerosis (ALS)

iQure Pharma

iQure Pharma trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Princeton, USA HQ
2019 Founded
9 Employees
EMA registrant Type
Company details
Status
Public
HQ
Princeton, USA
Founded
2019
Employees
9
Programs
2
Drugs
2
Patents
0
Intelligence · Clinical Trials

iQure Pharma clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to iQure Pharma programs — each row shows trial ID, program name, phase, status, and indication.

iQure Pharma trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for iQure Pharma.

  1. CT-AMT-130-02 — Phase 2

    Clinical update
  2. AMT-162-001 — Phase 2

    Clinical update

Trial registry

2 studies